Mydecine Innovations Group Inc C.MYCO

Alternate Symbol(s): MYCOF

Healthcare Advertising Agencies

Mydecine Innovations Group Inc. is a Canada-based biotechnology company. The Company is engaged in developing medications and therapies to address mental health disorders, such as nicotine addiction and posttraumatic stress disorder (PTSD). The Company conducts research and development on second generation compounds in Canada with a focus on developing and commercializing psychedelic-inspired regulated medicines. The Company has two lead 3,4-Methylenedioxymethamphetamine (MDMA) candidates. The Company is channeling its MYCO-005, MYCO-006, and MYCO-007 families of patent-pending second-generation MDMA and Psilocybin analogs through Applied Pharmaceutical Innovation (API). It utilizes artificial intelligence (AI) and pharma research infrastructure at the University of Alberta to develop and manufacture new medications to make them accessible to the general public upon Health Canada and Food and Drug Administration (FDA) approval.

CSE:MYCO - Post by User

Mydecine Innovations Group Inc

Bullboard Posts

Post by 9sheetson Feb 21, 2019 2:07am

176 Views

Post# 29392100

New Age Brands finally evolving

offers unique turnkey growing infrastructure and services for licensed growers and processors of luxury marijuana crops at its agri-campuses in Washington State. New Age Farm provides innovative solutions for growers and processors in the burgeoning industry. Additionally, New Age Farm's subsidiary, We Are Kured, LLC is focused on building a complementary online CBD and lifestyle company. The first product, a fully loaded, 250 mg disposable terpene infused, hemp derived CBD vaporizing pen has been on the market since early 2018.

Bullboard Posts

BMO evolves InvestorLine with enhanced tools for options trading